YOLFTbeta
41

EPS Bio Technology Corp.

4183 · TWO · Healthcare / Medical Devices

14.40TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close14.40
Open13.40
Day Range13.40 – 14.50
52-Week Range11.60 – 19.00
Volume11.00K
Market Cap341.53M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.41
Dividend Yield0.00%
Beta0.01
50-Day Avg14.11
200-Day Avg14.89

About

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOCheng-Hui Cho
  • Employees108
  • HeadquartersNo. 8, R&D Road III, Hsinchu City, Taiwan, 30076, Taiwan
  • Websitehttps://www.epsbio.com

Leadership

  • Cheng-Hui ChoPresident
  • Mr. Po-Hsiung KuoDeputy GM, CFO & Director
  • Zhitai HuangAccounting Supervisor
  • Chih-Tai HuangController
  • Ching-Nien LoVice President
  • Cheh-Heng LinVice President

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue459.35M477.60M480.28M463.45M470.17M451.08M499.70M
Growth (%)-+3.97%+0.56%-3.50%+1.45%-4.06%+10.78%
Cost of Revenue348.06M342.85M359.61M356.04M354.46M354.82M412.66M
Gross Profit111.29M134.75M120.67M107.42M115.71M96.27M87.04M
Gross Margin24.23%28.21%25.12%23.18%24.61%21.34%17.42%
Operating Expense83.56M91.10M93.76M75.22M90.79M92.76M93.54M
Operating Income27.73M43.65M26.91M32.20M24.92M3.51M-6.50M
Operating Margin6.04%9.14%5.60%6.95%5.30%0.78%-1.30%
EBITDA42.21M61.48M45.49M49.50M44.09M34.46M7.61M
EBITDA Margin9.19%12.87%9.47%10.68%9.38%7.64%1.52%
Net Income18.44M31.70M18.64M25.36M20.99M17.31M-7.87M
Net Income Margin4.01%6.64%3.88%5.47%4.46%3.84%-1.57%
R&D30.94M30.39M32.28M30.88M33.22M33.43M34.50M
R&D as % of Total Revenue6.74%6.36%6.72%6.66%7.07%7.41%6.90%
Interest Expense2.53M2.29M2.18M2.13M2.13M2.05M1.90M
Interest Expense % of Total Revenue0.55%0.48%0.45%0.46%0.45%0.46%0.38%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets534.61M546.97M577.45M527.76M543.16M541.89M533.25M
Total Liabilities240.55M237.82M278.18M219.41M237.13M237.34M252.14M
Total Equity294.07M309.15M299.27M308.36M306.04M304.55M281.11M
Cash175.78M221.87M203.42M178.66M195.29M128.94M123.08M
Total Debt28.38M131.93M126.47M121.40M115.81M110.14M-
Net Debt-147.40M-89.95M-76.95M-57.26M-79.47M-18.80M-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow21.85M79.91M32.08M5.00M55.17M-32.34M603.00K
Financing Cash Flow-21.83M-22.02M-34.02M-22.59M-28.91M-24.72M-
Capital Expenditure15.15M6.98M12.14M14.95M9.48M14.41M23.97M
Free Cash Flow6.69M72.92M19.95M-9.96M45.69M-46.75M-23.37M
Dividends Paid16.66M16.66M28.56M16.66M23.32M19.04M15.95M
FCF to OCF30.64%91.26%62.17%-199.18%82.82%144.56%-3874.96%
Dividend Paid to FCF248.88%22.85%143.19%-167.35%51.05%-40.73%-68.24%

Earnings

Report DateMay 14, 2017Aug 10, 2017Mar 19, 2020
EPS Estimate0.050.39-
EPS Actual-0.36-0.230.15
Surprise-820.00%-158.97%-
TimingAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap341.53M
Enterprise Value345.49M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.82
Price / Book1.27
EPS-0.41
Book Value11.23
Revenue (TTM)418.74M
Gross Profit (TTM)68.74M
EBITDA-9.71M
Profit Margin-2.35%
Operating Margin-0.54%
Return on Equity-3.62%
Return on Assets-2.68%
Shares Outstanding23.80M
Shares Float7.42M
Beta0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.67Aug 28, 2025
20241×
0.80Jun 24, 2024
20231×
0.98Jul 6, 2023
20221×
0.70Jul 12, 2022
20211×
1.20Jul 21, 2021
20201×
0.70Jul 13, 2020
20191×
0.70Jul 3, 2019
20181×
0.30Aug 27, 2018
20171×
0.80Aug 24, 2017
20161×
0.40Aug 29, 2016
20141×
0.10Oct 8, 2014
20131×
0.58Aug 20, 2013

Stock Splits

  • Oct 8, 20141040:1000